Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Min Zhan, Ze-bin Chen, Chang-cai Ding, Qiang Qu, Guo-qiang Wang, Sixi Liu & Fei-qiu Wen. (2021) Machine learning to predict high-dose methotrexate-related neutropenia and fever in children with B-cell acute lymphoblastic leukemia. Leukemia & Lymphoma 62:10, pages 2502-2513.
Read now
Read now
Dimitri Maamari, Habib El-Khoury, Omran Saifi, Samar A Muwakkit & Nathalie K Zgheib. (2020) Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia. Pharmacogenomics and Personalized Medicine 13, pages 295-317.
Read now
Read now
Pingli Yao, Xia He, Rong Zhang, Rongsheng Tong & Hongtao Xiao. (2019) The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis. Hematology 24:1, pages 10-19.
Read now
Read now
Maitane Umerez, Ángela Gutierrez-Camino, Carmen Muñoz-Maldonado, Idoia Martin-Guerrero & Africa Garcia-Orad. (2017) MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy. Pharmacogenomics and Personalized Medicine 10, pages 69-78.
Read now
Read now
Natalia Weich, Alejandro Roisman, Belén Cerliani, Hilda V. Aráoz, Lilien Chertkoff, Silvina M. Richard, Irma Slavutsky, Irene B. Larripa & Ariela F. Fundia. (2017) Gene polymorphism profiles of drug-metabolising enzymes GSTM1, GSTT1 and GSTP1 in an Argentinian population. Annals of Human Biology 44:4, pages 379-383.
Read now
Read now
Articles from other publishers (13)
Shivam Sharma, Leonardo Mariño-Ramírez & I. King Jordan. (2023) Race, Ethnicity, and Pharmacogenomic Variation in the United States and the United Kingdom. Pharmaceutics 15:7, pages 1923.
Crossref
Crossref
Evelien G. E. Hurkmans, Annouk C. A. M. Brand, Job A. J. Verdonschot, D. Maroeska W. M. te Loo & Marieke J. H. Coenen. (2022) Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review. BMC Cancer 22:1.
Crossref
Crossref
Yan Gong, Li Luo, Liu Wang, Jun Chen, Fen Chen, Yuanyuan Ma, Zhen Xu, Yiqi Sun, Lin Luo, Chen Shi & Xingang Li. (2021) Association of MTHFR and ABCB1 polymorphisms with MTX‐induced mucositis in Chinese paediatric patients with acute lymphoblastic leukaemia, lymphoma or osteosarcoma—A retrospective cohort study. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1557-1563.
Crossref
Crossref
Rim Frikha, Maha Ben Jemaa, Fakher Frikha, Ines Turki, Moez Elloumi, Leila Keskes, Hassen Kamoun & Tarek Rebai. (2020) Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia. Journal of Oncology Pharmacy Practice 27:6, pages 1382-1387.
Crossref
Crossref
Hedy Maagdenberg, Natanja Oosterom, Jolanda Zanen, Donato Gemmati, Rachael E. Windsor, Sandra G. Heil, Patricia Esperón, Shakila Jabeen, Guillermo J. Ruiz-Argüelles, Oliver Zolk, Susanne Hoerning, Charlotte Sleurs, Elixabet Lopéz-Lopéz, Mónica Moreno-Galván, Marry M. van den Heuvel-Eibrink, Anke H. Maitland-van der Zee & Bruce C. Carleton. (2021) Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 161, pages 103312.
Crossref
Crossref
Diego Alberto Bárcenas-López, Diana Karen Mendiola-Soto, Juan Carlos Núñez-Enríquez, Juan Manuel Mejía-Aranguré, Alfredo Hidalgo-Miranda & Silvia Jiménez-Morales. (2021) Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia. Translational Oncology 14:1, pages 100978.
Crossref
Crossref
Rim Frikha, Tarek Rebai, Ben Mahmoud Lobna, Fakher Frikha, Moez Mdhaffar, Imen Frikha, Moez Elloumi & Nouha Bouayed. (2018) Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience. Journal of Oncology Pharmacy Practice 25:5, pages 1182-1186.
Crossref
Crossref
Guillermo Gervasini & Sonia Mota-Zamorano. (2019) Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia. Current Drug Metabolism 20:4, pages 313-330.
Crossref
Crossref
Al-Motassem Yousef, Rand Farhad, Daniah Alshamaseen, Abrar Alsheikh, Mohammed Zawiah & Taha Kadi. (2019) Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology 83:4, pages 755-762.
Crossref
Crossref
Sonja Pavlovic, Nikola Kotur, Biljana Stankovic, Branka Zukic, Vladimir Gasic & Lidija Dokmanovic. (2019) Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment. Genes 10:3, pages 191.
Crossref
Crossref
C Zhu, Y W Liu, S Z Wang, X L Li, X L Nie, X T Yu, L B Zhao & X L Wang. (2017) Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis. The Pharmacogenomics Journal 18:3, pages 450-459.
Crossref
Crossref
Ana M. Soler, Natalia Olano, Yessika Méndez, Ana Lopes, Anaulina Silveira, Agustin Dabezies, Luis Castillo & Julio A. da Luz. (2017)
TPMT
and
NUDT
15
genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay
. British Journal of Haematology 181:2, pages 252-255.
Crossref
Crossref
Vid Mlakar, Patricia Huezo-Diaz Curtis, Chakradhara Satyanarayana Uppugunduri, Maja Krajinovic & Marc Ansari. (2016) Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use. International Journal of Molecular Sciences 17:9, pages 1502.
Crossref
Crossref